Aug 19, 2026 06:45AM
Aug 19, 2026 06:45AM
Aug 6, 2026 06:45AM
Aug 6, 2026 06:45AM
Aug 4, 2026 06:30AM
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM Gilead and Merck HIV pill shows strong results in Phase 3 trials
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jul 17, 2026 07:07AM
Jul 16, 2026 06:45AM
Jul 16, 2026 06:45AM
Jul 15, 2026 07:00AM
Jul 15, 2026 07:00AM Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
Jul 15, 2026 06:45AM
Jul 15, 2026 06:45AM
Jul 10, 2026 02:10PM
Jul 10, 2026 02:10PM
Jul 8, 2026 08:00AM
Jul 8, 2026 08:00AM
Jun 29, 2026 06:45AM Merck reaches deal to expand HIV drug access via ADAP programs
Jun 29, 2026 06:45AM
Jun 25, 2026 06:45AM
Jun 25, 2026 06:45AM
Jun 24, 2026 08:30AM
Jun 24, 2026 08:30AM
Jun 24, 2026 06:45AM
Jun 24, 2026 06:45AM European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resect
Jun 18, 2026 06:45AM
Jun 18, 2026 06:45AM
Jun 12, 2026 04:10PM
Jun 12, 2026 04:10PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:30PM Merck and Gilead discontinue lung cancer drug combination trial
Jun 8, 2026 04:30PM
Jun 3, 2026 09:00AM
May 29, 2026 06:49AM
May 29, 2026 06:45AM
May 22, 2026 07:55AM
May 22, 2026 07:55AM
May 13, 2026 08:30AM Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 12, 2026 06:45AM
May 12, 2026 06:45AM
May 7, 2026 08:00AM
May 5, 2026 08:45AM
May 5, 2026 08:45AM
Apr 30, 2026 06:30AM
Apr 21, 2026 02:11PM FDA approves Merck's IDVYNSO for HIV-1 treatment switch
Apr 21, 2026 02:11PM

330,173 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All